Embecta Corp. (EMBC)

Embecta Corp. (EMBC) is a healthcare company (medical instruments & supplies) based in the United States. The share price is $6.22, down 0.48% on the day, which values the company at $352.42M. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$6.22−0.48% today
Market value
$352.42M
P/E ratio
4.2×last 12 months
Forward P/E
3.5×
Dividend yield
7.36%
Funk Score
53/100
Against its own history
Well below its usual priceusual price $14.16
200-week average
$14.3557% below

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Embecta Corp. in more detail

EMBC trades at 4.2× its last twelve months' earnings, 3.5× next year's expected earnings, 0.3× sales. Measured against its own history, the price is 56% below what its usual multiples would imply ($14.16) — well below its usual price. It sits 57% below its 200-week average of $14.35.

Over the last five fiscal years Embecta Corp. has compounded revenue -0.1% a year, earnings per share -26.4% a year, free cash flow -16.8% a year. Its Funk Score is 53 out of 100 (financial strength 2.6, profitability 7.4, growth 1.2, value 10.0, each out of 10).

In its favour: High return on invested capital. Worth checking: Share count keeps rising; Gross margin is shrinking.

1 of the superinvestors tracked here hold EMBC, including Stephen Yacktman (0.3% of the portfolio).

Superinvestors holding EMBC

1 of the investors tracked here report a position in their latest 13F filing.

Embecta Corp. (EMBC): questions and answers

What is EMBC's P/E ratio?

Embecta Corp. trades at 4.2× its last twelve months' earnings and 3.5× next year's expected earnings. At its fiscal year-ends over the past 4 years the P/E ranged from 7.4× to 12.3×, with a median of 9.6×.

What is Embecta Corp.'s market cap?

Embecta Corp. is valued at $352.42M at a share price of $6.22.

Is EMBC overvalued or undervalued?

Against its own history, EMBC is well below its usual price: the price is 56% below the $14.16 implied by the median multiples it has traded at (price / earnings, price / sales, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is EMBC above its 200-week moving average?

No. EMBC is 56.6% below its 200-week average of $14.35. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Embecta Corp. growing?

Over the last five fiscal years Embecta Corp.'s revenue grew -0.1% a year and its earnings per share -26.4% a year.

Does EMBC pay a dividend?

Yes. Embecta Corp.'s dividend yield is 7.36%, or $0.04 a share a year, paying out 31% of earnings.

Cite this page

Funkfolio, “Embecta Corp. (EMBC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/EMBC

Underlying data: Yahoo Finance; company filings with the SEC.